Global Ophthalmic Drugs Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 5.3% - ResearchAndMarkets.com

June 12, 2018

DUBLIN--(BUSINESS WIRE)--Jun 12, 2018--The “Ophthalmic Drugs Market by Indication, Type, Dosage Form, Technology, Distribution Channel, and Therapeutic Class - Global Opportunity Analysis and Industry Forecast, 2017-2023” report has been added to ResearchAndMarkets.com’s offering.

The global ophthalmic drugs market was valued at $29,613 million in 2016, and is expected to reach $42,663 million by 2023, registering a CAGR of 5.3% from 2017 to 2023.

Ophthalmic drugs are preparations used for the treatment of eye diseases and disorders such as cataract, glaucoma, color blindness, diabetic macular edema, CMV retinitis, and age-related macular degeneration. The ophthalmic drugs market is witnessing significant growth, due to increase in prevalence of eye disorders and rise in use of combination therapies for treatment of ophthalmic disorders, especially glaucoma. Combination therapies have various advantages over traditional medication such improvement in patient compliance and efficacy.

The ophthalmic drugs market is segmented based on indication, type, distribution channel, dosage form, technology, therapeutic class, and geography. Depending on indication, the market is divided into dry eye, glaucoma, infection/inflammation/allergy, retinal disorders, and others. On the basis of type, the market is bifurcated into prescription drugs and over-the-counter drugs. By Distribution Channel, it is categorized into hospital pharmacies, online pharmacies, drug stores, and others. According to dosage form, it is classified into liquid ophthalmic drug forms, semisolid ophthalmic drug forms, solid ophthalmic drug forms, multicompartment drug delivery systems, and other ophthalmic drug forms.

Companies Mentioned:

Santen Pharmaceutical Co., Ltd. Bausch & Lomb Inc. Shire Plc Alcon Genentech, Inc. Allergan, Plc Sun Pharmaceutical Industries Limited Actavis Generics Regeneron Pharmaceuticals, Inc. Pfizer Inc. Abbott Medical Optics, Inc. Carl-Zeiss AG Ellex Medical Lasers Ltd. Essilor International S.A. Hoya Corporation Insight Vision Inc. Nidek Co. Ltd. Novagali Pharma S A Topcon Corporation Ziemer Ophthalmic Systems AG

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Ophthalmic Drugs Market, by Indication

5 Ophthalmic Drugs Market, by Type

6 Ophthalmic Drugs Market, by Distribution Channel

7 Ophthalmic Drugs Market, by Dosage Form

8 Ophthalmic Drugs Market, by Therapeutic Class

9 Ophthalmic Drugs Market, by Technology

10 Ophthalmic Drugs Market, by Region

11 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/jg7fh7/global_ophthalmic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180612005827/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Optical Disorders Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/12/2018 08:34 AM/DISC: 06/12/2018 08:34 AM


Update hourly